Investors and VCs
Below is a curated list of the most active Swiss VCs, meaning that they have made the highest number of investments in Swiss startups from 2021 to 2024.
In addition to these local investors, we also highlight the top global venture capital firms that have been actively investing in Switzerland during the same period — a strong indicator of Switzerlands international appeal and relevance in the global startup ecosystem.
Data provided by startupticker.ch
Most Active VCs
in Switzerland
-
Swisscom Ventures
Focus on later stage
ICT
Participated in funding round of >100 mio.
Invested in Unicorn
Global VCs
| VC | Swiss portfolio companies | Asset under Management in $ bn |
|---|---|---|
| Sequoia Capital | Ledgy, Yokoy | $ 41.06 |
| HSG (Hongshan) | RIVR | $ 18.79 |
| Andreessen Horowitz | Nym | $ 39.38 |
| Union Square Ventures | Transmutex | $ 2.89 |
| khosla ventures | Aktiia, Univerbal | $ 7.177 |
| General Catalyst | EthonAI, Sonarsource | $ 16.59 |
| Index Ventures | EthonAI, Nexthink | $ 14.97 |
| Accel | Viso | $ 22.08 |
| Wellington Partners | Corflow, Onward, Polares Medical | $ 1.14 |
| Bessemer Venture Partners | Anybotics, Kandou | $ 14.34 |
| EQT Life Sciences | Noema Pharma, Asceneuron, Nouscom | $ 1.65 |
| Forbion | Numab, Noema Pharma, VectivBio | $ 6.07 |
| Gilde Healthcare | Noema Pharma, Argá Medtech, Swis Dental Solutions | $ 2.92 |
| GV (Google Ventures) | RhyGaze, Sanos, Scandit | >$ 10 |
| Lightspeed | NovaMea, ImmunOs Therapeutics, | $ 18.88 |
| Novo Holding | Windward Bio, Numab, Alentis Therapeutics | $ 0.17 |
| OrbiMed | vVardis, Windward Bio, Alentis Therapeutics | $ 8.63 |
| Sofinnova Partners | Noema Pharma, Asceneuron, GlycoEra | $ 4.56 |
| Versant Ventures | Bright Peak Therapeutics, Nouscom, Cimeio Therapeutics | $ 3.86 |
| Cherry Ventures | Voliro | $ 0.72 |